27.7 C
New York
Wednesday, June 10, 2026

Tag: presentation

Cellebrite Announces Upcoming Investor Events on June 10, 2026

TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and...

G-III Apparel Group, LTD. Reports First Quarter Fiscal 2027 Results and Raises Earnings Guidance

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NasdaqGS: GIII) (“G-III” or the “Company”) today reported results for the first quarter of fiscal year 2027, ended April 30, 2026.

Bimergen Energy (BESS) to Present Path to $400 Million Revenues in The Small Cap Showcase & Water Tower Research Insights, June 9, 2026

Newport Beach, CA, June 05, 2026 (GLOBE NEWSWIRE) -- Bimergen Energy Corporation [NYSE American: BESS, BESS.WS] today announced that Bob Brilon, Co-CEO will participate in The Small Cap Showcase & WTR Insights, taking place on June 9, 2026, in New York City.

Ferrellgas Partners, L.P. Reports Third Quarter Fiscal Year 2026 Results

FERRELLGAS PARTNERS, L.P. REPORTS THIRD QUARTER FISCAL YEAR 2026 RESULTS

Haemonetics Updates Financial Reporting Segments

BOSTON, June 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient...

Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR

The study showed that orelabrutinib was safe and well tolerated in participants with SLE.

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

The intravenous part of the Phase IIb clinical dose-finding trial PROCEED met its primary endpoint, with bocunebart demonstrating a statistically significant reduction in monthly...

Saputo Reports Financial Results for the Fourth Quarter and Fiscal 2026

MONTREAL, June 04, 2026 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the fourth quarter and fiscal year ended on March 31, 2026. All amounts in this news release are in millions of Canadian dollars (CDN), except per share amounts, unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS) Accounting Standards. The results of the Dairy Division (Argentina), which were previously reported under the International Sector, have been classified as discontinued operations, with comparative information presented accordingly, and with its assets and liabilities presented as held for sale.

Saputo Reports Financial Results for the Fourth Quarter and Fiscal 2026

MONTREAL, June 04, 2026 (GLOBE NEWSWIRE) -- Saputo Inc. (TSX: SAP) (we, Saputo or the Company) reported today its financial results for the fourth quarter and fiscal year ended on March 31, 2026. All amounts in this news release are in millions of Canadian dollars (CDN), except per share amounts, unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS) Accounting Standards. The results of the Dairy Division (Argentina), which were previously reported under the International Sector, have been classified as discontinued operations, with comparative information presented accordingly, and with its assets and liabilities presented as held for sale.

Resideo Provides Update on Planned Spin-Off of ADI Global Distribution

Files Amended Form 10 Registration StatementAnnounces Scheduling Details for Resideo and ADI Investor DaysReaffirms Previously Announced Second Quarter and Full Year 2026 Outlook; Releases...

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference

CAMBRIDGE, Mass., June 4, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon...

HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026

BOSTON, June 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target...

X-energy Reports First Quarter 2026 Results

X-energy Reports First Quarter 2026 Results

Shoplazza Helps Australian Merchants Turn Product Ideas Into Ready-to-Sell Online Stores With AI

SYDNEY, June 4, 2026 /PRNewswire/ -- Shoplazza, a global AI-native eCommerce platform, is helping Australian merchants move faster from product idea to online store...

- A word from our sponsors -

spot_img
HomeTagsPresentation